Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia

Clinics

Volumn 62, Issue 1, 2007, Pages 69-76

  Terrabuio Jr , Alberto Antonio ^a   Parra, Edwin Roger ^a   Farhat, Cecília ^a   Capelozzi, Vera Luiza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autopsies; Diffuse alveolar damage; Immunocompromised patients; Secondary interstitial pneumonia

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BRAZIL; CAUSE OF DEATH; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DIABETES MELLITUS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; ISOLATION AND PURIFICATION; LUNG ALVEOLUS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK; STATISTICAL MODEL; TRANSPLANTATION; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BRAZIL; CAUSE OF DEATH; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DIABETES COMPLICATIONS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY ALVEOLI; STEROIDS; TRANSPLANTATION;

EID: 33847686886     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322007000100011     Document Type: Article

References (49)

1. Perez R. Interstitial lung disease: causes, treatment, and prevention. Ethn Dis. 2005;15 (2 suppl 2):S45-8.
2. Maimon N, Almog Y. Pulmonary infiltrates in the immunocompromised host. Isr Med Assoc J. 2003;5:112-5.
3. Cunha B. Pneumonias in the compromised host. Infect Dis Clin North Am. 2001;15:591-612.
4. Chan K, Allen S. Infectious pulmonary complications in lung transplant recipients. Semin Respir Infect. 2002;17:291-302.
5. Brown M, Miller R, Muller N. Acute lung disease in the immunocompromised host: CT and pathologic examination findings. Radiology. 1994;190:247-54.
6. Hiorns M, Screaton N, Muller N. Acute lung disease in the immunocompromised host. Radiol Clin North Am. 2001;39:1137-51.
7. Gosselin M. Diffuse lung disease in the immunocompromised non-HIV patient. Semin Roentgenol. 2002;37:37-53.
8. Crawford S. Noninfectious lung disease in the immunocompromised host. Respiration. 1999;66:385-95.
9. Alam S, Chan K. Noninfectious pulmonary complications after organ transplantation. Curr Opin Pulm Med. 1996;2:412-18.
10. Conces D. Noninfectious lung disease in immunocompromised patients. J Thorac Imaging. 1999;14:9-24.
11. Suh G, Kang E, Chung M, Lee K, Han J', Kitaichi M, et al. Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest. 2006;129:753-61.
12. Quefatieh A, Stone C, DiGiovine B, Toews G, Hyzy R. Low hospital mortality in patients with acute interstitial pneumonia. Chest. 2003;124:554-9.
13. Roychowdhury M, Pambuccian S, Aslan D, Jessurun J, Rose A, Manival J, et al. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center. Arch Pathol Lab Med. 2005;129:366-71.
14. Lee Y, Wu C, Hsu H, Huang P, Chang Y. Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients. J Thorac Cardiovasc Surg. 2005;129:984-90.
15. Canzian M, Soeiro A de M, Taga MF de L, Barbas CSV, Capelozzi VL. Correlation between surgical lung biopsy and autopsy findings and clinical data in patients with diffuse pulmonary infiltrates and acute respiratory failure. Clinics. 2006;61:425-432.
16. Carvalho MGF, Rodrigues MAM, Marques ME, Franco M, Montenegro MR. Lesões do trato gastrointestinal na síndrome da imunodeficiência adquirida: estudo de 45 necrópsias consecutivas. Rev Soc Bras Med Trop. 1994;27:135-41.
17. Gutierrez EB, Zanetta DMT, Saldiva PHN, Capelozzi VL. Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in São Paulo, Brazil. Pathol Res Pract. 2002;198:339-46.
18. Lowndes CM, Bastos FI, Giffin KM, Vaz dos Reis AC, d'Orsi E, Alary M. Differential trends in mortality from AIDS in men and women in Brazil (1984-1995). AIDS. 2000;14:1269-73.
19. Nash G. Pathologic features of the lung in the immunocompromised host. Hum Pathol. 1982;13:841-58.
20. de Medeiros CR, Moreira VA, Pasquini R. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation. Bone Marrow Transplant. 2000;26:443-4.
21. Juric G, Tentor D, Jakic-Razumovic J. Autopsy findings and clinical diagnoses: retrospective study of 3,117 autopsies. Croat Med J. 1999;40:71-6.
22. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, et al. ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004,30:51-61. Epub 2003 Oct 16.
23. Hagerty J, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt). 2003;4:263-71. Review.
24. Fortun J, Martin-Davila P, Moreno S, De Vicente E, Nuno J, Candelas A, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl. 2002;8:1065-70.
25. Marik PE. Fungal infections in solid organ transplantation. Expert Opin Pharmacother. 2006;7:297-305.
26. Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:24-31. Review.
27. Chang GC, Chang KM, Wu CL, Chiang CD. Clinical patterns among invasive pulmonary aspergillosis patients with and without recent intensive immunosuppressive therapy. J Formos Med Assoc. 2001;100:762-6.
28. Iida H, Ri M, Niimi K, Harada T, Sao H. Histopathological findings of pulmonary complications in 16 patients who received allogeneic hematopoietic stem cell transplants. Rinsho Ketsueki. 2005;46:1273-8.
29. Chamilos G, Luna M, Lewis R, Bodey G, Chemaly R, Tarrand J, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006; 91:986-9. Epub 2006 Jun 1.
30. Humbert M, Lombard-Roux P, Cerrina J. Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis. Am J Respir Crit Care Med. 1994;149:1681-5.
31. Barry SM, Johnson MA, Janossy G. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant. 2000;26:591-7.
32. Stals F, Steinhoff G, Wagenaar S, van Breda Vriesman J, Haverich A, Dormans P, et al. Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response. Lab Invest. 1996;74:343-52.
33. Oldakowska-Jedynak U, Niewczas M, Ziolkowski J, Mucha K, Foroncewicz B, Bartlomiejczyk I, et al. Cytomegalovirus infection as a common complication following liver transplantation. Transplant Proc. 2003;35:2295-7.
34. Magro C, Ali N, Williams JD, Allen J, Ross P Jr. Cytomegalovirus- associated pulmonary septal capillary injury sine inclusion body change: a distinctive cause of occult or macroscopic pulmonary hemorrhage in the immunocompetent host. Appl Immunohistochem Mol Morphol. 2005;13:268-72.
35. Dworniczak S, Ziora D, Basta L, Piwowarska G, Jastrzebski D, Oklek K, et al. Human cytomegalovirus serological status in patients with interstitial lung diseases. Przegl Epidemiol. 2003;57:431-7.
36. Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: Role of antiphospholipid antibodies. J Infect. 2006 May 12; [Epub ahead of print].
37. Camus P, Costabel U. Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med. 2005;26:458-81. Review.
38. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000;20:1245-59. Review.
39. Jandrlic M, Kalenic S, Labar B, Nemet D, Jakic-Razumovic J, Mrsic M, et al. An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis. 1995;14:768-74.
40. Gentile G, Micozzi A, Girmenia C, Iori AP, Donati PP, Capria S, et al. Pneumonia in allogeneic and autologous bone marrow recipients. Chest. 1993;104:371-5.
41. Stoblen F, Blumhard G, Kaisers U, Raakow R, Bechstein WO, Neuhaus P. Outcome of severe pneumonias after orthotopic liver transplantation. Transplant Proc. 1994;26:3681-2.
42. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology. 1995;21:1328-36.
43. Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow MR, Aubry MC, et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest. 2005;128:1385-92.
44. Li GS, Ye QF, Xia SS, Chen ZS, Zeng FJ, Lin ZB, et al. Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int. 2002;1:330-4.
45. Nakase K, Tsuji K, Nagaya S, Tamaki S, Tanigawa M, Ikeda T, et al. Acute interstitial pneumonitis during chemotherapy for haematological malignancy. Eur J Cancer Care (Engl). 2005;14:336-41.
46. Walter EA, Bowden RA. Infection in the bone marrow transplant recipient. Infect Dis Clin North Am. 1995;9(4):823-47. Review.
47. Hoelz C, Negri EM, Lichtenfels AJ, Concecao GM, Barbas CS, Saldiva PH, et al. Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies. Pathol Res Pract. 2001;197:521-30.
48. Madani MM, Jamieson SW. Chronic thromboembolic pulmonary hypertension. Curr Treat Options Cardiovasc Med. 2000;2:141-8.
49. Parambil JG, Savci CD, Tazelaar HD, Ryu JH. Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy. Chest. 2005;127:1178-83.